As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.
13 Analysts have issued a MeiraGTx Holdings plc forecast:
13 Analysts have issued a MeiraGTx Holdings plc forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 38 38 |
367%
367%
|
|
| Gross Profit | 10 10 |
-
|
|
| EBITDA | -145 -145 |
6%
6%
|
|
| EBIT (Operating Income) EBIT | -158 -158 |
7%
7%
|
|
| Net Profit | -158 -158 |
69%
69%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
| Head office | Cayman Islands |
| CEO | Alexandria Forbes |
| Employees | 378 |
| Founded | 2015 |
| Website | meiragtx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


